Chest Therapy and Postural Education in Children With Cerebral Palsy

May 9, 2019 updated by: Moreno Bermejo, Universidad Complutense de Madrid

Chest Therapy and Postural Control in Children With Crhonic Neurological Patology

INTRODUCTION: Neurological Chronic disease leads to motor disability and associated pathologies. Numerous studies agree that the lack of prevention and treatment in pulmonary health in children with disabilities results in increased morbidity and mortality, increased medical care and costs in care, and, for patients and their caregivers, decrease in their quality of life OBJECTIVE: The objective of this study is to assess if children with chronic neurological disease and respiratory disease benefit from airway clearance techniques and postural hygiene workshops to optimize their respiratory status and quality of life. PATIENTS AND METHODS: Multicenter experimental study before-after with intervention of chest therapy and workshops of postural hygiene in 30 children from 0 to 6 years with chronic neurological affectation and respiratory complications. Respiratory clinical variables, volume of expectorated secretions, PedsQL pediatric quality of life questionnaires were evaluated and the number of exacerbations due to respiratory complications was recorded.

Study Overview

Detailed Description

There are few studies that apply and evaluate respiratory physiotherapy and / or postural hygiene in children with neurological affections. This study aims to improve the quality and effectiveness of physiotherapy interventions in paediatric patients with neurological problems and respiratory symptomatology, providing scientific evidence to respiratory physiotherapy protocols that are carried out in daily clinical practice and implementing the practice of therapeutic education on postural hygiene.

HYPOTHESIS: Children with neurological chronic disease and respiratory affection benefit from mucociliary clearance techniques and workshops on postural hygiene to optimize respiratory status and quality of life.

OBJECTIVES

  • To evaluate the effectiveness of mucociliary clearance techniques in improving respiratory clinical signs and to increase expectoration of bronchial secretions in children with chronic neurological disease.
  • To analyse the effectiveness of mucociliary clearance techniques combined with workshops to improve the quality of life of children with chronic neurological disease with respiratory complications.
  • Establish the effectiveness of mucociliary clearance techniques and workshops to reduce the number of exacerbations due to respiratory infection in children with chronic neurological disease.
  • To determine the effectiveness of mucociliary clearance techniques and workshops to reduce hospital admissions for respiratory complications in children with chronic neurological disease.
  • MATERIAL AND METHODS It is an experimental study before - after a single group of children with non-progressive chronic neurological affectation (Cerebral Palsy, Down Syndrome, encephalopathies, ...) and respiratory involvement with intervention of chest therapy and workshops of postural hygiene directed to their parents or guardians Each individual has been their own control in the successive evaluations. The physiotherapist who has performed the techniques of chest therapy and workshops has been the same as the physiotherapist evaluator, so that there has been neither simple nor double blind.

The project was previously approved by the Clinical Research Ethics Committee of the San Carlos Clinical University Hospital (internal code nº 15/152-E); He was awarded the 2014 Research Fellowship of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR).

ESTIMATION OF SAMPLE SIZE The sample size necessary to obtain a good internal validity was calculated, considering a normal distribution of the data, making a population estimate according to Granmo for paired means (repeated in a group). And the Bonferroni correction was taken into account, that is, the significance of at least 0.05 divided by the number of comparisons (in this case 8) was considered for each contrast.

So, estimating a significance of 0.00625 (0.05 / 8) and a power of 0.8, in a bilateral contrast, 27 subjects are required to detect a difference equal to or greater than 3.5 units. A standard deviation of 5 is assumed.

The participants were recruited from four centres of early care and foundations of the Community of Madrid. From their respective centres, all the parents of children with chronic neurological syndromes, who could enter the study according to the inclusion and exclusion criteria previously described, participated in the project.

The informed consent of the parents or guardians of each participant was filed outside their medical history and they were informed of the confidentiality of the data according to the Organic Law 15/99 of December 13 of Data Protection of personal character.

Subsequently, a first evaluation of the participants was performed, in which the descriptive data, the clinical exams, the number of exacerbations that each participant underwent during the 6 months prior to the beginning of the study were collected and the PedsQL quality of life questionnaires Through a personal interview with the parents.

After this first evaluation, the clinical evaluations were performed, including the clinical exams of the participants before and after each session. And, after each session, the volume of secretions expectorated by each participant was measured. In the last session (session 6) the PedsQL quality of life questionnaires were completed again.

Finally, in the evaluation of evolutionary control, clinical examinations were performed, the PedsQL quality of life questionnaires were again completed and the number of exacerbations due to respiratory complications that each participant had during the six months after the study was started.

Chest therapy was performed twice a month. The intervention of the workshops was done every 3 months.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 6 years (CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients whose parents or guardians have signed informed consent.
  • Patients of both sexes whose ages are between 0 and 6 years.
  • Diagnosis of PC, encephalopathies and syndromes with non-progressive chronic neurological involvement, with respiratory complications (Pneumonias or Bronchitis).

Exclusion Criteria:

  • Patients affected by immunodeficiency or hemato-oncological process.
  • Previous respiratory pathology in itself (not consistent with its underlying pathology)
  • Patients with cardiovascular instability.
  • Patients with drained pneumothorax.
  • Patients with recent pneumonectomy.
  • Patients with severe bullae.
  • Patients with hemoptysis.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Sample

30 patients of both sexes aged between 0 and 6 years with chronic neurological involvement with respiratory complications.

Individual sessions of chest therapy every fifteen days for three months, in total 6 respiratory physiotherapy sessions of 30 minutes each were performed. And the postural hygiene workshops were given to the parents, this educational intervention was carried out at the beginning of the study, at 3 months and at 6 months from the beginning. Each intervention lasted 4 hours with theoretical and practical part.

The sessions of chest therapy were based on airway clearance techniques (hyper manual insufflations, abdominal thoracic compressions and manually assisted cough)
Other Names:
  • Airways clearance techniques
Postural hygiene workshops were taught through a theoretical presentation with the help of slides and practical exercises in small groups (2-4 parents per group).
Other Names:
  • Postural hygiene workshop

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Quality of Life Related to Health (HRQoL) at 6 month
Time Frame: The PedsQL questionnaires were completed at the beginning of the study, at 6 months after the start of the study.
It was objectified through a personal interview with the parents, the PedsQL ™ Questionnaire on Pediatric Life Quality in Spanish version was used with the corresponding permission of use. The PedsQL ™ Generic Module investigates four areas or dimensions of the child's HRQoL: Physical, Emotional, Social and School Functioning. To calculate the HRQoL measure, the items were linearly transformed using a five-point Likert scale, on a scale of 0-100.
The PedsQL questionnaires were completed at the beginning of the study, at 6 months after the start of the study.
Change from number of hospitalizations
Time Frame: The number of hospitalizations for respiratory complications that each participant had during the six months before and after the start of the study was recorded.
Number of admissions due to respiratory complications. It was valued through a personal interview with the parents.
The number of hospitalizations for respiratory complications that each participant had during the six months before and after the start of the study was recorded.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pulmonary auscultation
Time Frame: It was assessed through study completion, an average of 6 month .
The presence or absence of adventitious noises was assessed. The conserved vesicular murmur corresponds to normal respiratory noise and indicates good pulmonary ventilation. The adventitious sounds assessed are crackles, wheezing and hypoventilation, indicating poor pulmonary ventilation and bronchial obstruction. The auscultation was assessed using the 3M ™ Littmann® Classic II Pediatric Stethoscope.
It was assessed through study completion, an average of 6 month .
Pulsoximetry
Time Frame: It was evaluated through study completion, an average of 6 month .
It was measured by the finger Pulsioximetro, M-Pulse ™ pediatric.
It was evaluated through study completion, an average of 6 month .
Heart rate
Time Frame: It was measured through study completion, an average of 6 month.
It was evaluated using the finger Pulse Oximeter, M-Pulse ™ pediatric
It was measured through study completion, an average of 6 month.
Respiratory Rate
Time Frame: It was measured through study completion, an average of 6 month.
The number of breathing cycles was valued with the help of a crono for 60 seconds in the rest of the participants, in a noise-free environment.
It was measured through study completion, an average of 6 month.
Sputum
Time Frame: It was measured through study completion, an average of 6 month .
It was measured in millimeters of secretions with a millimetric glass.
It was measured through study completion, an average of 6 month .
Number of emergency visits
Time Frame: The number of visits to the emergency department due to respiratory complications that each participant had during the six months before and after the study was recorded.
Number of emergency visits due to respiratory complications. It was valued through a personal interview with the parents.
The number of visits to the emergency department due to respiratory complications that each participant had during the six months before and after the study was recorded.
Number of visits to pediatrician
Time Frame: The number of pediatric visits for respiratory complications that each participant had during the six months before and after of the study was recorded.
Number of visits to pediatrician due to respiratory complications. It was valued through a personal interview with the parents.
The number of pediatric visits for respiratory complications that each participant had during the six months before and after of the study was recorded.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Thoracic mobility
Time Frame: It was measured through study completion, an average of 6 month.
The measurement of maximal inspiration, maximal expiration and the difference between both (thoracic expansion) in the sitting position was made using a tape measure marked in increments of 0.1 cm at the level of the fourth intercostal space.
It was measured through study completion, an average of 6 month.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Inmaculada M Moreno, Doctora, Sociedad Española de Cirugía y neumología Torácica

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2013

Primary Completion (ACTUAL)

March 1, 2014

Study Completion (ACTUAL)

May 1, 2015

Study Registration Dates

First Submitted

April 23, 2019

First Submitted That Met QC Criteria

May 9, 2019

First Posted (ACTUAL)

May 10, 2019

Study Record Updates

Last Update Posted (ACTUAL)

May 10, 2019

Last Update Submitted That Met QC Criteria

May 9, 2019

Last Verified

May 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Complutense University

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Child

Clinical Trials on Chest Therapy

3
Subscribe